[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-339919-105":59,"doc-detail-339919-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","the-role-of-bud31-in-clear-cell-renal-cell-carcinoma-prognostic-significance-alternative-splicing-and-tumor-immune-environment","The role of BUD31 in clear cell renal cell carcinoma - prognostic significance, alternative splicing, and tumor immune environment","","BUD31 is a spliceosome-associated factor linked to cancer, and this study evaluates its role in clear cell renal cell carcinoma (ccRCC). Expression, prognostic value, mutation landscape, genomic instability, and tumor immune microenvironment were assessed using TCGA/GTEx and analyses including IHC, survival testing, Cox regression, and nomogram building. In ccRCC, BUD31 knockdown combined with RNA sequencing identified BUD31-regulated alternative splicing events, especially cell-cycle genes.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/the-role-of-bud31-in-clear-cell-renal-cell-carcinoma-prognostic-significance-alternative-splicing-and-tumor-immune-environment/339919/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/the-role-of-bud31-in-clear-cell-renal-cell-carcinoma-prognostic-significance-alternative-splicing-and-tumor-immune-environment/339919.png","ImageObject",300,407,{"name":92,"@type":93},"Asher","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-03","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What aspects of BUD31 were investigated in this study?","Question",{"text":112,"@type":113},"The study examined BUD31 expression, prognostic value, mutation profile, genomic instability, tumor immune environment, and its role in ccRCC through alternative splicing and cell cycle regulation.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was BUD31 expression analyzed across cancers?",{"text":117,"@type":113},"BUD31 expression was analyzed using TCGA and GTEx databases spanning 33 cancers, supplemented by IHC staining for protein-level assessment in relevant tissues.",{"name":119,"@type":110,"acceptedAnswer":120},"What functional effects did BUD31 knockdown have in ccRCC?",{"text":121,"@type":113},"BUD31 knockdown inhibited ccRCC cell proliferation, migration, and invasion in vitro and reduced tumor growth in vivo.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},339919,1790925333,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":46,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":31,"preview_page_count":19,"preview_urls":144},687197207639,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Clinical and Experimental Medicine (2024) 24:191 [https://doi.org/10.1007/s10238-024-01451-8](https://doi.org/10.1007/s10238-024-01451-8)  \nThe role of BUD31 in clear cell renal cell carcinoma: prognostic significance, alternative splicing, and tumor immune environment  \nXiaoliang Wu1 · Ruixin Fan2 · Yangjun Zhang2 · Chen Duan2 · Xiangyang Yao2 · Kai Liu2 · Dongxu Lin1 · Zhong Chen1  \nReceived: 26 June 2024 / Accepted: 26 July 2024 / Published online: 13 August 2024 © The Author(s) 2024  \nAbstract  \nBUD31, a splicing factor, is linked to various cancers. This study examines BUD31's expression, prognostic value, mutation profile, genomic instability, tumor immune environment, and role in clear cell renal cell carcinoma (ccRCC), focusing on cell cycle regulation via alternative splicing. BUD31 expression was analyzed using TCGA and GTEx databases across 33 cancers. Techniques included IHC staining, survival analysis, Cox regression, and nomogram construction. Mutation landscape, genomic instability, and tumor immune microenvironment were evaluated. Functional assays on ccRCC cell lines involved BUD31 knockdown, RNA sequencing, and alternative splicing analysis. BUD31 was upregulated in multiple tumors, including ccRCC. High BUD31 expression correlated with worse survival outcomes and was identified as an independent predictor of poor prognosis in ccRCC. High BUD31 expression also correlated with increased genomic instability and a less active immune microenvironment. BUD31 knockdown inhibited cell proliferation, migration, and invasion in vitro and reduced tumor growth in vivo. RNA sequencing identified 390 alternative splicing events regulated by BUD31, including 17 cell cycle-related genes. KEGG analysis highlighted pathways involved in cell cycle regulation, indicating BUD31's role in promoting cell cycle progression through alternative splicing. BUD31 is upregulated in various tumors and is associated with poor outcomes, increased genomic instability, and a suppressed immune microenvironment in ccRCC. BUD31 promotes cell cycle progression via alternative splicing, suggesting it as a prognostic biomarker and potential therapeutic target in ccRCC.  \nKeywords BUD31 · Clear cell renal cell carcinoma · Prognosis · Cell cycle · Alternative splicing · Cancer biomarker  \nIntroduction  \nRenal cell carcinoma (RCC) is a prevalent and highly aggressive malignancy, with the clear cell variant (ccRCC) being the most common subtype. ccRCC is notorious for its resistance to conventional chemotherapeutic and radiotherapeutic treatments, presenting significant challenges in oncology [1] . The discovery and characterization of biomarkers are crucial for understanding cancer pathophysiology and developing targeted therapeutic strategies. In this context,  \nXiaoliang Wu and Ruixin Fan have contributed equally to this study.  \n* Zhong Chen [1991tj0590@hust.edu.cn](1991tj0590@hust.edu.cn)  \n1 Department of Urology, Tongji Medical College, Tongji Hospital, Huazhong University of Science and Technology, Wuhan 430000, Hubei, China  \n2 Department of Urology, Zhongnan Hospital of Wuhan University, Wuhan 430000, Hubei, China  \nBUD31 has recently emerged as a gene of significant interest due to its involvement in various cellular processes and its potential role in cancer progression [2–4] .  \nBUD31, a spliceosome-associated protein, plays a critical role in alternative splicing, a post-transcriptional process that generates multiple mRNA variants from a single gene, thereby contributing to proteomic diversity and cellular complexity [4–8] . Dysregulation of alternative splicing has been implicated in various cancers [9–12], including ccRCC, where it may drive tumor progression by affecting the expression of genes involved in key pathways such as cell cycle regulation [13–15] . Despite previous studies indicating that BUD31 is upregulated in several tumor types and suggesting its role in oncogenesis [2, 4, 16] . Its specific contributions to ccRCC remain","cbCaidt4CQpcbar1","https://ap.wps.com/l/cbCaidt4CQpcbar1","pdf",10957571,"English","# Abstract\n# Introduction\n## Background on RCC and ccRCC\n## Role of BUD31 and alternative splicing in cancer\n## Study aims and approach","[{\"question\":\"What aspects of BUD31 were investigated in this study?\",\"answer\":\"The study examined BUD31 expression, prognostic value, mutation profile, genomic instability, tumor immune environment, and its role in ccRCC through alternative splicing and cell cycle regulation.\"},{\"question\":\"How was BUD31 expression analyzed across cancers?\",\"answer\":\"BUD31 expression was analyzed using TCGA and GTEx databases spanning 33 cancers, supplemented by IHC staining for protein-level assessment in relevant tissues.\"},{\"question\":\"What functional effects did BUD31 knockdown have in ccRCC?\",\"answer\":\"BUD31 knockdown inhibited ccRCC cell proliferation, migration, and invasion in vitro and reduced tumor growth in vivo.\"}]","The role of BUD31 in clear cell renal cell carcinoma - prognostic significance, alternative splicing, and tumor immune environment | PDF",1790033089,[145,149,153,157],{"page_no":8,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/93807fa89d4faa9d2a7ea69224b68c1a.webp",983,1305,{"page_no":14,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c59608cedffac1aef2700b00cf28ba6f.webp",982,1304,{"page_no":81,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e4850973ad947aeadf20735383dd45a9.webp",981,1303,{"page_no":19,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4a5e1b288a82b0ce2f12732a09a1e515.webp",980,1301]